Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pollard

Showing results (291-300 of 294) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 294 results.
Plos Pathogens|July 6, 2021
Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaquesKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Plos Pathogens|April 20, 2022
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Science Translational Medicine|December 1, 2022
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year laterEmma C Milligan, Katherine Olstad, Caitlin A Williams, et al.
Pageof 30

Showing results (291-300 of 294) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 294 results.
Plos Pathogens|July 6, 2021
Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaquesKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Plos Pathogens|April 20, 2022
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Science Translational Medicine|December 1, 2022
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year laterEmma C Milligan, Katherine Olstad, Caitlin A Williams, et al.
Pageof 30